REVERSAL OF LUPUS-ERYTHEMATOSUS-LIKE DISEASE WITH DANAZOL

The Lancet

Volumn 316, Issue 8195, 1980, Pages 651-

  Masse, R ^a   Youinou, P ^a   Dorval, J C ^a   Cledes, J ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; DANAZOL; IMMUNOGLOBULIN;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; CASE REPORT; DRUG THERAPY; LUPUS ERYTHEMATOSUS; PRELIMINARY COMMUNICATION; THERAPY;

ADULT; CASE REPORT; COMPLEMENT 1 INACTIVATORS; COMPLEMENT 4; DANAZOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNADIENES;

EID: 0018859738     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(80)90326-8     Document Type: Letter

References (10)

1. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test
2. Hereditary angioneurotic edema: a clinical survey
3. Treatment of hereditary angioedema with danazol: Reversal of clinical and biochemical abnormalities
4. Treatment of acquired Cl-inhibitor deficiency with danazol
5. Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema
6. Danazol's failure to suppress autoimmunity in NZB/NZW Fl mice
7. Genetic deficiency of the second composent of complement (C2) associated with systemic lupus erythematosus: Relation of the complement abnormality and disease manifestations
8. Amniotic fluid acetylcholinesterase as a possible diagnostic test for neuraltube defects in early pregnancy
9. Isoenzymes of soluble and membrane-bound acetylcholinesterase in bovine splanchnic nerve and adrenal medulla
10. Acetylcholinesterase in human amniotic fluid: an index of fetal neural development?